Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.76
-0.08 (-0.62%)
Apr 28, 2026, 1:28 PM EDT - Market open
TNXP Market Cap
TNXP has a market cap or net worth of $181.26 million as of April 28, 2026. Its market cap has increased by 62.82% in one year.
Market Cap
181.26M
Enterprise Value
-24.93M
1-Year Change
62.82%
Ranking
Category
Stock Price
$12.76
Market Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $181.26M, an increase of 2,385.18%. That is a compound annual growth rate of 60.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 182.40M | -5.77% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 190.95M |
| Whitehawk Therapeutics | 190.20M |
| Korro Bio | 185.91M |
| Acumen Pharmaceuticals | 185.59M |
| Unicycive Therapeutics | 183.98M |
| Precision BioSciences | 181.65M |
| Cartesian Therapeutics | 178.94M |
| Corbus Pharmaceuticals Holdings | 178.43M |